Endoscopy
DOI: 10.1055/a-2354-3352
Innovations and brief communications

Endoscopic ultrasound-guided entero-colostomy with lumen-apposing metal stent as a rescue treatment for malignant intestinal occlusion: a multicenter study

1   Therapeutic GI Endoscopy Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
2   Department of Systems Medicine, Gastroenterology Unit, University ‘Tor Vergata’ of Rome, Rome, Italy
,
Serena Stigliano
1   Therapeutic GI Endoscopy Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
,
Dario Biasutto
1   Therapeutic GI Endoscopy Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
,
Nicolò Citterio
3   Therapeutic GI Endoscopy Unit, TherFondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
4   Gastroenterology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
,
5   Gastroenterology Unit, Hospital of Imola, University of Bologna, Bologna, Italy
,
5   Gastroenterology Unit, Hospital of Imola, University of Bologna, Bologna, Italy
,
6   Gastrointestinal Endoscopy Unit, Humanitas Mater Domini, Castellanza, Italy – Humanitas University, Milan, Italy
,
7   Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
8   Department of Interventional Endoscopy and Endoscopic Surgery, Hopital Privé des Peupliers, Paris, France
,
Giuseppe Tonini
9   Department of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
,
Francesco Maria Di Matteo
1   Therapeutic GI Endoscopy Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
› Author Affiliations


Abstract

Background Surgery is the first-choice treatment for malignant intestinal obstruction (MIO); however, many patients are deemed unfit for surgery. Endoscopic ultrasound-guided entero-colostomy (EUS-EC) with a lumen-apposing metal stent (LAMS) could represent a new treatment option.

Methods Consecutive patients undergoing EUS-EC for MIO from November 2021 to September 2023 at four European tertiary referral centers were retrospectively enrolled. Multidisciplinary meetings determined whether patients were unsuitable for surgery or colonic stent placement, or refused surgery. The primary outcome was technical success of EUS-EC and secondary outcomes were clinical outcome, safety, and hospital stay.

Results 12 patients were enrolled (median age 72.5 [range 42–85] years; 58.3% female). Colonic adenocarcinoma was the primary tumor in 75.0% of patients and 91.7% had stage IV disease. Technical success was 100%. No LAMS misdeployment or other procedural adverse events occurred; three patients (25.0%) had severe post-procedural complications. Clinical success was achieved in 10 patients (83.3%), with 5 (50.0%) resuming chemotherapy after the procedure. Median post-procedural hospital stay was 9 (1–20) days and median overall survival was 47.5 (2–270) days.

Conclusions EUS-EC was a feasible technique and could be considered a possible alternative to standard approaches for MIO in highly selected patients.

Supplementary Material



Publication History

Received: 17 November 2023

Accepted after revision: 26 June 2024

Accepted Manuscript online:
26 June 2024

Article published online:
14 August 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany